Clinical Trials Browser

INDUSTRY × Ovarian Neoplasms × quisinostat × Clear all

NCT02948075 2018-06-27

Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

Phase 2 Completed

Ovarian Neoplasms